In CRC, overactivation of EGFR is often associated with poorer prognosis (7, 8); however, existing studies have demonstrated that high NRG1 expression in CRC patients correlates with better prognosis (9–11). The gene discussed is EGFR; the disease is colorectal carcinoma.